Barry H Dash bought $8,610 of ELTP
director at ELITE PHARMACEUTICALS INC /NV/. 30,000 shares at an average of $0.29, traded Aug 19, 2026, filed Sep 10, 2026.
Score components
- +15RoleDirector
- 0Trade size$9k at market
- -5Relative to holdingsUnder 1% of holdings (0.9%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001324222-26-000001, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | POpen-market purchase Common Stock | +30,000 | $0.29 | $8,610 | 3,265,555 | 33 d ago |
Related signals
Other insiders at ELITE PHARMACEUTICALS INC /NV/ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche EVP Operations | $499k 800,000 shares | -19% | |
| 18Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Elite Pharmaceuticals Inc /nv/ EVP Operations | $262k 500,000 shares | -22% | |
| 31Weak | ELTPbuy ELITE PHARMACEUTICALS INC /NV/ | Kirko Kirkov Chief Commercial Officer | $9,640 16,366 shares | - | |
| 25Weak | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche EVP Operations | $116k 200,000 shares | -8% | |
| 54Moderate | ELTPsell ELITE PHARMACEUTICALS INC /NV/ | Douglas Plassche SVP of Operations | $562k 1,133,932 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.